HENRY FORD WEST BLOOMFIELD HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $3.9M
- Transactions
- 416
- Companies
- 40
- Average per transaction
- $9,455
Who reported the payments
| Genentech, Inc. | $1,989,443 |
| Exelixis Inc. | $309,511 |
| Roche TCRC, Inc. | $272,571 |
| Servier Bioinnovation | $213,835 |
| F. Hoffmann-la Roche AG | $149,028 |
| Amgen | $135,509 |
| Janssen Research & Development, LLC | $109,685 |
| Genentech USA, Inc. | $96,500 |
| Fresenius USA Marketing, Inc. | $91,058 |
| Novartis | $74,973 |
| Bavarian Nordic A/s | $64,059 |
| Morphosys AG | $50,119 |
| Ethicon Endo-surgery Inc. | $46,324 |
| Intercept Pharmaceuticals, Inc. | $43,441 |
| Macrogenics, Inc. | $42,080 |
| Servier Pharmaceuticals LLC | $32,000 |
| Hoffmann-la Roche Limited | $29,055 |
| Intercept Pharma Europe Ltd. | $26,184 |
| Arcutis Biotherapeutics, Inc. | $16,913 |
| Stemline Therapeutics Inc. | $16,654 |
| Bausch Health US, LLC | $14,266 |
| Haemonetics Corporation | $14,200 |
| Mirum Pharmaceuticals, Inc. | $13,909 |
| Medtronic | $12,500 |
| Fresenius Medical Care Renal Therapies Group, LLC. | $11,365 |
| Stryker | $9,125 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | $7,100 |
| Genmab U.S., Inc. | $6,084 |
| Arrow International, Inc. | $5,000 |
| Teleflex LLC | $5,000 |
| MDD US Operations, LLC | $3,753 |
| Zimmer Biomet | $3,302 |
| Pharmacyclics LLC, An Abbvie Company | $3,000 |
| Morphosys, US Inc. | $3,000 |
| Insmed, Inc. | $2,500 |
| Karyopharm Therapeutics Inc. | $2,000 |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,000 |
| Bausch & Lomb Americas Inc. | $2,000 |
| Sanofi US Services Inc. | $1,815 |
| Ocular Therapeutix, Inc. | $1,574 |